Pharma III – Pharmaceutical and Biotech Regulation and Innovation

Upon completing the course, participants should be able to:

Knowledge

• Understand how the organizational set-up supports how projects are prioritized in pharmaceutical and biotech companies.
• Understand the rationale behind key business processes in the pharmaceutical and biotech industry - and how to move research from academia into start-ups or existing companies.
• Gain an insight into the Danish innovation ecosystem and its possibilities.
• Basic knowledge on legal concepts that needs to be addressed while setting up a start-up company.
   

Skills

• Describe the process of evaluating research results and securing IP rights, how to secure financing in the early phases, and key research and business concepts in building a start-up based on translational research or in the collaboration with biotech or pharma.
   

Competences

• Explain the rationale behind a project management portfolio, including how companies decide from a pool of competing projects to create a profitable portfolio that achieve the company’s strategic goals.
• Discuss and understand commercial decision structures in pharmaceutical and biotech companies and start-ups.
• Discuss and understand potential factors influencing the IP, legal and financing processes from research lab to start-up company or license agreement with an established company.